Kidney Stone Retrieval Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Kidney Stone Retrieval Devices Market Trends and Insights

Shift toward single-use flexible ureteroscopes

Clinical evidence shows that single-use scopes remove reprocessing costs, cut cross-contamination risk, and deliver comparable stone-free outcomes to reusable equivalents. Per-case expenditure ranges from USD 1,300–3,180, making them economical for facilities handling fewer than 50 cases annually. Boston Scientific’s LithoVue platform spearheads adoption, while Olympus will introduce its first single-use ureteroscope in Europe in H2 FY2025. CMS transitional pass-through payments under code C1747 bolster the kidney stone retrieval devices market by improving outpatient economics.

Wider reimbursement for minimally-invasive procedures

Medicare recognizes ureteroscopic lithotripsy as reasonable and necessary, and CMS recently assigned Category I CPT codes to Olympus’s iTind system, signaling willingness to remunerate validated innovation^{[1]Source: Centers for Medicare & Medicaid Services, “National Coverage Determination for Kidney Stone Treatment,” cms.gov}. Field reimbursement managers and ROI calculators from Boston Scientific help providers navigate billing, smoothing adoption paths in the kidney stone retrieval devices market .

Rapid adoption of thulium-fiber and burst-wave lithotripsy

Thulium-fiber lasers shorten operative time by 20% and save USD 69 per case versus holmium:YAG systems. Japanese case series recorded basketing times of 7 minutes compared with 21 minutes for legacy lasers while maintaining equal stone-free rates. Compact consoles needing only standard outlets suit smaller clinics and expand the kidney stone retrieval devices market.

AI-assisted endoscopic navigation reducing OR time

More than 69 studies highlight AI benefits in stone recognition and outcome prediction. Early robotic flexible ureteroscopy platforms achieved 93.48% stone-free rates for stones <4 mm in initial clinical use. AI-ready optics increase differentiation inside the kidney stone retrieval devices market, yet regional data-governance gaps and uneven digital literacy slow mainstreaming^{[2]Source: APACMed, “Realizing the Value of AI in MedTech within Asia Pacific,” apacmed.org}.

High capital cost of digital ureteroscopes

Reusable flexible scopes cost USD 50,000–150,000 and require supporting lasers and imaging stacks exceeding USD 200,000, delaying ROI for resource-constrained sites. Single-use scopes shift cost to operating budgets but can top USD 3,000 per case at low volume, complicating procurement decisions in the kidney stone retrieval devices market.

Device-related infection and encrustation risk

Stent encrustation risk rises after prolonged dwell times, sometimes demanding secondary surgeries. The FDA issued a class I recall on a renal-aspiration system in 2025, underscoring regulatory vigilance in the kidney stone retrieval devices market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Device Type: Ureteroscopes Extend Their Lead

The ureteroscope segment accounted for 33.92% of the kidney stone retrieval devices market share in 2025, which translated to roughly USD 1.04 billion of the 2025 kidney stone retrieval devices market size. Dominance stems from the instrument’s essential role in visualising and accessing calculi throughout the urinary tract, while recent upgrades in digital imaging and smaller outer diameters improve manoeuvrability and patient safety. Single-use digital ureteroscopes accelerate volume growth because hospitals can eliminate repair downtime, reprocessing expense and cross-contamination risk. Reusable fleets remain relevant in high-volume academic centres that can amortise reprocessing infrastructure and secure multiyear service contracts. Retrieval baskets and guidewires move in parallel since every ureteroscopic case requires at least one ancillary tool for fragment extraction or device placement.

Lithotripters represent the fastest-growing device class with a projected 5.12% CAGR to 2031, led by thulium-fibre laser consoles that deliver faster fragmentation with lower retropulsion than holmium:YAG systems medical.olympusamerica.com. Compact footprint, standard-outlet power requirements and embedded safety controls allow smaller ambulatory sites to adopt high-energy lasers that once belonged only in tertiary theatres. Access sheaths with suction ports shorten operative time by lowering intrarenal pressure and clearing debris in real time, a benefit that dovetails with advanced laser performance. Manufacturers are layering artificial-intelligence algorithms on top of digital video streams to automate stone detection and propose optimal laser settings, adding another point of differentiation in the kidney stone retrieval devices market. Environmental sustainability also shapes buying criteria; vendors now highlight recyclable packaging and lower water consumption during scope cleaning to align with hospital ESG goals.

By End-User: Hospitals Anchor Demand while Ambulatory Centres Accelerate

Hospitals generated 61.78% of the kidney stone retrieval devices market size in 2025, or around USD 1.9 billion, thanks to 24/7 capability, multidisciplinary backup and access to capital for premium optics. Emergency departments funnel acute renal-colic cases directly into surgical suites, underpinning steady baseline volumes. Academic centres also serve as early adopters of AI-ready scopes and simulation tools, influencing regional referral patterns. Budget committees increasingly scrutinise total cost of ownership, leading many systems to deploy mixed fleets: reusable scopes for predictable high-volume lists and single-use models for infectious or anatomically complex cases. Vendor service bundles that combine training, predictive maintenance and data dashboards help hospitals optimise asset utilisation and justify capital expense.

Ambulatory surgical centres (ASCs) are the fastest-growing channel with a 6.05% CAGR to 2031, propelled by CMS transitional pass-through payments that offset disposable scope costs and align reimbursement with outpatient economics. Same-day discharge, flexible scheduling and lower facility fees appeal to payers and patients alike, shifting straightforward sub-2 cm stones away from inpatient settings. ASCs favour single-use scopes because the devices remove the need for costly reprocessing rooms and biofilm-monitoring protocols. Specialty urology clinics move in a similar direction, often leveraging group-purchasing contracts or mobile laser-rental services to control overhead. The migration of routine procedures to outpatient venues broadens geographic access, fosters price competition and cements the kidney stone retrieval devices market as an integral component of value-based care pathways.

Geography Analysis

North America controlled 42.12 % of the kidney stone retrieval devices market in 2025, buoyed by comprehensive payer coverage and high surgeon density. Medicare reimbursement for transurethral lithotripsy and CMS pass-through payments for single-use scopes solidify procedural economics. Boston Scientific reported 23.5 % Urology segment growth in Q1 2025 as hospitals and ASCs upgraded to digital single-use platforms. Canada mirrors this trend under provincial funding, although capital constraints lengthen purchasing cycles for AI-ready consoles.

Asia-Pacific represents the fastest-growing region, expanding at a 6.86 % CAGR through 2031. Rising prevalence, urbanisation and improving insurance penetration fuel procedure volumes. China’s national data show a decisive tilt toward ureteroscopic treatment; Japan leads in thulium-fiber laser utilisation, and India’s private-insurance growth unlocks demand for cost-effective single-use scopes. Governments pursue Access-Capability-Trust frameworks to harmonise device approvals, upskill surgeons and build digital infrastructure—steps vital for sustained expansion of the kidney stone retrieval devices market.

Europe exhibits steady growth, supported by Medical Device Regulation compliance and ESG-weighted procurement criteria. Olympus is set to launch its first single-use ureteroscope in H2 FY2025, catering to hospitals aiming to reduce cross-infection and water consumption. Training deficits loom as the Simulator Availability Index for ureteroscopy trainers declined in recent surveys, hinting at potential workforce bottlenecks doi.org. South America and the Middle East participate through technology-transfer partnerships, whereas Africa faces financing hurdles and remains an untapped frontier of the kidney stone retrieval devices market.

Regulatory Landscape

In the United States, many kidney stone retrieval accessories and endourology tools used in ureteroscopic stone management (such as ureteral stone dislodgers/baskets) fall under FDA Class II controls and commonly follow the 510(k) premarket notification pathway, requiring demonstration of substantial equivalence to predicate devices. Recent clearances in 2026 highlight ongoing regulatory throughput for both disposable retrieval tools and emerging lithotripsy modalities, including FDA 510(k) clearances for SonoMotion's Break Wave device (January 2026) and a subsequent Special 510(k) update (April 2026), as well as a 510(k) clearance in April 2026 for Zhejiang Soudon Medical Technology Co., Ltd. for a disposable stone extraction basket.

In Europe, kidney stone retrieval devices are governed by the Medical Devices Regulation (MDR) (EU) 2017/745, which places heavier emphasis on comprehensive technical documentation, clinical evaluation, and post-market clinical follow-up (PMCF). The MDR transition continues to influence manufacturer compliance planning, with increased scrutiny on areas central to this market such as sterilization validation, biocompatibility, and performance data for nitinol or metal-based instruments used in retrieval baskets, guidewires, and access systems.

Value Chain Analysis

The value chain spans specialized raw materials and components (notably nitinol for memory-alloy baskets, PTFE and other low-friction polymers for liners and tubing, and stainless steel for support elements) through precision manufacturing and assembly steps such as extrusion of polymer shafts, coating (hydrophilic/low-friction), and cleanroom assembly aligned with ISO 13485 quality systems. For many retrieval baskets, access sheaths, and guide sheaths, tight process control is critical to ensure torque response, kink resistance, and consistent opening/closure behavior of distal retrieval elements.

OEM/ODM production plays a meaningful role in scaling capacity for disposable and semi-disposable product lines, while branded device companies differentiate via system integration (single-use ureteroscopes, suction-enabled access sheaths, and ancillary retrieval tools), physician training, and service support. Distribution typically runs through direct sales to hospitals and ambulatory surgical centers for capital and procedural ecosystem products, alongside tendering and group purchasing for high-throughput consumables; supply risk remains most visible around specialty alloys (including nitinol) and coating/sterilization throughput that can constrain lead times for single-use portfolios.

Market Opportunities and Future Outlook

Whitespace is opening around non-invasive and lower-acuity care pathways that reduce dependence on operating room time and anesthesia, supported by recent regulatory progress for new lithotripsy approaches. In January 2026, SonoMotion received FDA 510(k) clearance for its Break Wave device for urinary stone fragmentation (with an additional Special 510(k) clearance in April 2026), providing a concrete example of office-oriented, ultrasound-based fragmentation technology moving through mainstream regulatory gates. This creates room for device vendors to build complementary retrieval and fragment-management workflows that reduce residual fragments, including combinations of fragmentation tools with retrieval baskets, guidewires, and access platforms.

Within ureteroscopy-driven care, procurement is shifting from standalone instruments to integrated systems that target stone-free outcomes and intrarenal pressure management during retrograde intrarenal surgery. Market activity around suction-assisted ureteral access sheaths and single-use digital ureteroscopes supports opportunities for bundled offerings across scopes, suction-enabled access, and retrieval accessories that simplify setup for ambulatory surgical centers and help standardize procedures. Updated 2026 urolithiasis guidance from professional bodies such as the AUA and EAU reinforces minimally invasive decision pathways by stone size and location, creating a clearer framework for hospitals and ASCs to align equipment standardization, training, and consumable utilization across ureteroscopes, lithotripters, and retrieval tools.